Zipher Medical Affairs CO., LLC

Articles by Zipher Medical Affairs CO., LLC

Defining the Course & Navigating the Finish Line

ByZipher Medical Affairs CO., LLC

February 25th 2022

Sponsored Content

Latest Updated Articles

Trending on PharmExec

FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma

Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds